Houston data analytics firm acquired by Austin agency

m&a moves

Statistical Vision has been rebranded as Hahn Stats. Image via Getty Images

Statistical Vision, a Houston-based data and analytics firm, has been scooped up by Austin-based marketing and communications agency Hahn Public for an undisclosed amount.

The deal expands Hahn Public to a 48-person agency with combined annual revenue exceeding $10 million. Statistical Vision has been rebranded as Hahn Stats.

“Our clients come to us drowning in data — sales transactions, marketing information, commodity prices, import and export data, demographics, weather forecasts, etcetera,” Michael Griebe, co-founder and chief statistical officer of what now is Hahn Stats, says in a news release. “We build predictive analytic models to answer specific questions and to point our clients towards revenue growth.”

Griebe and Dirk Van Slyke founded Statistical Vision in 2014. The company's local office is at The Cannon West Houston. Hahn Stats LLC also has an office in Denver.

The data and analytics prowess developed by Statistical Vision will benefit Hahn Public clients like Houston-based ZTERS, Whataburger, the Texas Department of Agriculture, Beef-Loving Texans, H-E-B’s Central Market, Vital Farms, the Propane Education & Research Council, OneGas, GPA Midstream, the East Texas Electric Cooperative, and the Northeast Texas Regional Mobility Authority.

Jeff Hahn, principal of Hahn Public, says the acquisition of Statistical Vision and its data and analytics capabilities will help Hahn Public’s array of food and energy clients, who “continue to face a rapidly changing and uncertain landscape.”

Other businesses under the Hahn umbrella are Apron Food & Beverage Communications, Predictive Media Network, and White Lion Interactive.

Statistical Vision shares key data points it's watching as companies return to work amid the COVID-19 outbreak. Getty Images

Houston data startup analyzes COVID-19 risks as companies return to work

Guest column

In an effort to better help our clients, and frankly all of us, maneuver these uncertain times and to better understand what the upcoming months are likely to bring, we have applied our data science expertise to create a structural model of the spread of COVID-19. The aim of the national model is to determine specifically how mobility and weather impact the local transmission rates while controlling for population density, population immunity rate and the fact that people are taking more precautions.

When I discuss COVID19 with other Houstonians, I'm often asked "We're going back to work — there's traffic! Why haven't cases spiked?"

First, it is worth noting that cases and deaths have increased again in Harris County. But, the question is still valid. Greg Abbott started allowing things to open six weeks ago and we are only starting to see a rise now.

Fortunately, our model (being quantitative and multivariate) can explain why cases may not have 'spiked' the way that was expected. There are four main reasons why cases are only starting to tick up now:

  1. There has not been a 'spike' in people leaving their homes. While Greg Abbott did allow restaurants, movie theaters and malls to begin re-opening on April 30, there was not a sudden spike in people leaving their homes. Indeed, the "people staying home" index, according to Google Mobility Data, peaked on April 1 at 22 percent above normal and has gradually decreased ever since. In Harris County, the extent people are staying at home stands at 14 percent above normal as of May 29 (unfortunately, Google Mobility Data reports 7 to 10 days after the fact.) So, from the peak 'stay at home' measure, we were only a third the way back to normal last week.
  2. Temperatures have increased. Our model indicates that warmer temperatures decrease the transmission rate of COVID19. Our model does not posit a mechanism, but we can rule out both geographic explanations and behavioral explanations, which leaves us with the compelling reason to believe that temperatures matter.
  3. People's behaviors when they do go out have changed. These changes — everything from masks, to skipping hand shakes, to readily available hand sanitizer, to keeping your distance, to staying home when you're feeling sick — have an important and measurable impact on the spread.
  4. Kids are not back in school yet. While our model does not directly measure the impact of kids being in school, the estimate our model produces measuring the importance of staying at home (2.6) is higher than they should be (2, mathematically speaking). We suspect that's because we are missing an important cohort that started staying at home at the same time mobile phone users started staying at home - kids that don't have cell phones. So, while it may seem like we are most of the way back to normal, with regards to going out, being summer time in Houston, kids are not at school, which is likely keeping the rate of spread down.
All of that said, the gradual increase in people leaving their homes has had an impact. And now, cases and deaths are starting to increase. Our model reminds us that there are a variety of factors impacting the transmission rate. Right now, temperatures, people's behaviors and schools being out work in our favor. Come September, two of those three will turn the other way.
------
Michael Griebe is the co-founder and chief statistical officer at Houston-based Statistical Vision. To read more about the company's initiative, click here.
This week's episode of the Houston Innovators Podcast highlights 11 different entrepreneurs at a live recording at The Cannon Houston's grand opening event. Courtesy of Quy Tran/The Cannon

Meet the innovators working out of The Cannon Houston's brand new space

Houston innovators podcast episode 5

Last week, The Cannon Houston premiered its new digs in West Houston with a grand opening event attended by an incredible group of innovators, entrepreneurs, friends, family, and even puppies.

InnovationMap and the Houston Innovators Podcast had a presence at the festivities as well, which has allowed us to put together a special edition of the podcast. Rather than recording an interview with one entrepreneur in studio, this week's episode features 11 interviews with over a dozen innovators.

Here's who all you'll hear from — in order — in this episode:

  • Werner Winterboer of SapMok, a South African sustainable shoe making company that's looking to expand in Houston.
  • Brad Greer of DrySee, a liquid bandage company that's created a wetness indicator that allows for a patient to know if their bandage has been compromised thus preventing infection risks.
  • Chris Bayardo of Bayardo Safety LLC, a small compliance company that uses tech to optimize the oil and gas industry's compliance issues.
  • Dirk Van Slyke of Statistical Vision, a marketing consultancy that taps into data and metrics to help organizations take their company to the next level.
  • Aaron Knape of sEATz, an app that has perfected the mobile food and drink ordering process in stadiums.
  • Matt and Adam Woods of Skippermyboat, a tourism startup that helps travelers easily connect with boating adventures all over the world.
  • Mike T. Brown of Win-Win, a sports tech company that gamifies the donation process for causes supported by professional athletes.
  • Alex Taghi, Aimee Robert, and Jeffery Abel of Co-Counsel, the coworking concept for lawyers and attorneys.
  • Jeff Miller of Potentia, an education and staffing platform that helps place autistic employees with their right employer.
  • Drew Wadley with MiTyket, which has created a software that can prevent price gouging in the live entertainment industry.
  • Bret Bloch with Four Tower LLC, which provides integrated solutions for projects and operations.

Check out the episode below and subscribe wherever you get your podcasts.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Intuitive Machines forms partnership with Italian companies for lunar exploration services

to the moon

Houston-based space technology, infrastructure and services company Intuitive Machines has forged a partnership with two Italian companies to offer infrastructure, communication and navigation services for exploration of the moon.

Intuitive Machines’ agreement with the two companies, Leonardo and Telespazio, paves the way for collaboration on satellite services for NASA, a customer of Intuitive Machines, and the European Space Agency, a customer of Leonardo and Telespazio. Leonardo, an aerospace, defense and security company, is the majority owner of Telespazio, a provider of satellite technology and services.

“Resilient, secure, and scalable space infrastructure and space data networks are vital to customers who want to push farther on the lunar surface and beyond to Mars,” Steve Altemus, co-founder and CEO of Intuitive Machine, said in a news release.

Massimo Claudio Comparini, managing director of Leonardo’s space division, added that the partnership with Intuitive Machines is a big step toward enabling human and robotic missions from the U.S., Europe and other places “to access a robust communications network and high-precision navigation services while operating in the lunar environment.”

Intuitive Machines recently expanded its Houston Spaceport facilities to ramp up in-house production of satellites. The company’s first satellite will launch with its upcoming IM‑3 lunar mission.

Intuitive Machines says it ultimately wants to establish a “center of space excellence” at Houston Spaceport to support missions to the moon, Mars and the region between Earth and the moon.

Houston hospitals win $50M grant for ibogaine addiction treatment research

ibogaine funding

The Texas Health and Human Services Commission has awarded $50 million to UTHealth Houston in collaboration with The University of Texas Medical Branch at Galveston (UTMB Health) to co-lead a multicenter research trial to evaluate the effect of ibogaine, a powerful psychoactive compound, on patients suffering from addiction, traumatic brain injury and other behavioral health conditions.

The funding will establish a two-year initiative—known as Ibogaine Medicine for PTSD, Addiction, and Cognitive Trauma (IMPACT)—and a consortium of Texas health institutions focused on clinical trials and working toward potential FDA-approved treatments.

The consoritum will also include Texas Tech University, Texas Tech University Health Sciences Center El Paso, The University of Texas at Austin, The University of Texas Health Science Center at San Antonio, The University of Texas at Tyler, The University of Texas Rio Grande Valley, Texas A&M University, The University of North Texas Health Science Center, Baylor College of Medicine and JPS Health Network in Dallas.

Ibogaine is a plant-based, psychoactive substance derived from the iboga shrub. Research suggests that the substance could be used for potential treatment for patients with traumatic brain injuries, which is a leading cause of post-traumatic stress disorders. Ibogaine has also shown potential as a treatment for addiction and other neurological conditions.

UTHealth and partners will focus on ways that ibogaine can treat addiction and associated conditions. Meanwhile, UT Austin and Baylor College of Medicine will concentrate on using it to treat traumatic brain injury, especially in veterans, according to a news release from the institutions.

The consortium will also support drug developers and teaching hospitals to conduct FDA-approved clinical trials. The Texas Health and Human Services Commission will oversee the grant program.

“This landmark clinical trial reflects our unwavering commitment to advancing research that improves lives and delivers the highest standards of care,” Dr. Melina Kibbe, UTHealth Houston president and the Alkek-Williams Distinguished Chair, said in the news release. “By joining forces with outstanding partners across our state, we are building on Texas’ tradition of innovation to ensure patients struggling with addiction and behavioral health conditions have access to the best possible outcomes. Together, we are shaping discoveries that will serve Texans and set a model for the nation.”

The consortium was authorized by the passage of Senate Bill 2308. The bill provides $50 million in state-matching funds for an ibogaine clinical trial managed by a public university in partnership with a drug company and a hospital.

“This is the first major step towards the legislature’s goal of obtaining FDA approval through clinical trials of ibogaine — a potential breakthrough medication that has brought thousands of America’s war-fighters back from the darkest parts of depression, anxiety, PTSD, and chronic addiction,” Texas Rep. Cody Harris added in the release. “I am excited to walk alongside UTHealth Houston and UTMB as these stellar institutions lead the nation in a first-of-its-kind clinical trial in the U.S.”

Recently, the University of Houston also received a $2.6 million gift from the estate of Dr. William A. Gibson to support and expand its opioid addiction research, which includes the development of a fentanyl vaccine that could block the drug's ability to enter the brain. Read more here.

Tesla no longer world's biggest EV maker as sales fall for second year

Tesla Talk

Tesla lost its crown as the world’s bestselling electric vehicle maker as a customer revolt over Elon Musk’s right-wing politics, expiring U.S. tax breaks for buyers and stiff overseas competition pushed sales down for a second year in a row.

Tesla said that it delivered 1.64 million vehicles in 2025, down 9% from a year earlier.

Chinese rival BYD, which sold 2.26 million vehicles last year, is now the biggest EV maker.

It's a stunning reversal for a car company whose rise once seemed unstoppable as it overtook traditional automakers with far more resources and helped make Musk the world's richest man. The sales drop came despite President Donald Trump's marketing effort early last year when he called a press conference to praise Musk as a “patriot” in front of Teslas lined up on the White House driveway, then announced he would be buying one, bucking presidential precedent to not endorse private company products.

For the fourth quarter, Tesla sales totaled 418,227, falling short of even the much reduced 440,000 target that analysts recently polled by FactSet had expected. Sales were hit hard by the expiration of a $7,500 tax credit for electric vehicle purchases that was phased out by the Trump administration at the end of September.

Tesla stock fell 2.6% to $438.07 on Friday.

Even with multiple issues buffeting the company, investors are betting that Tesla CEO Musk can deliver on his ambitions to make Tesla a leader in robotaxi services and get consumers to embrace humanoid robots that can perform basic tasks in homes and offices. Reflecting that optimism, the stock finished 2025 with a gain of approximately 11%.

The latest quarter was the first with sales of stripped-down versions of the Model Y and Model 3 that Musk unveiled in early October as part of an effort to revive sales. The new Model Y costs just under $40,000 while customers can buy the cheaper Model 3 for under $37,000. Those versions are expected to help Tesla compete with Chinese models in Europe and Asia.

For fourth-quarter earnings coming out in late January, analysts are expecting the company to post a 3% drop in sales and a nearly 40% drop in earnings per share, according to FactSet. Analysts expect the downward trend in sales and profits to eventually reverse itself as 2026 rolls along.

Musk said earlier last year that a “major rebound” in sales was underway, but investors were unruffled when that didn't pan out, choosing instead to focus on Musk's pivot to different parts of business. He has has been saying the future of the company lies with its driverless robotaxis service, its energy storage business and building robots for the home and factory — and much less with car sales.

Tesla started rolling out its robotaxi service in Austin in June, first with safety monitors in the cars to take over in case of trouble, then testing without them. The company hopes to roll out the service in several cities this year.

To do that successfully, it needs to take on rival Waymo, which has been operating autonomous taxis for years and has far more customers. It also will also have to contend with regulatory challenges. The company is under several federal safety investigations and other probes. In California, Tesla is at risk of temporarily losing its license to sell cars in the state after a judge there ruled it had misled customers about their safety.

“Regulatory is going to be a big issue,” said Wedbush Securities analyst Dan Ives, a well-known bull on the stock. “We're dealing with people's lives.”

Still, Ives said he expects Tesla's autonomous offerings will soon overcome any setbacks.

Musk has said he hopes software updates to his cars will enable hundreds of thousands of Tesla vehicles to operate autonomously with zero human intervention by the end of this year. The company is also planning to begin production of its AI-powered Cybercab with no steering wheel or pedals in 2026.

To keep Musk focused on the company, Tesla’s directors awarded Musk a potentially enormous new pay package that shareholders backed at the annual meeting in November.

Musk scored another huge windfall two weeks ago when the Delaware Supreme Court reversed a decision that deprived him of a $55 billion pay package that Tesla doled out in 2018.

Musk could become the world's first trillionaire later this year when he sells shares of his rocket company SpaceX to the public for the first time in what analysts expect would be a blockbuster initial public offering.

View All Listings